Morning Break: Trump, Clinton Spar on ACA; Suicidal Med Students; Fine For Mylan

— Health news and commentary from around the Web, gathered by the MedPage Today staff

Last Updated October 11, 2016
MedpageToday

"No, Trump, Canadians do not flee en masse for US health care," says Julia Belluz of Vox. The claim was part of an exchange about the ACA between the presidential candidates at last night's debate.

Medical school is making many students suicidal, says medical student Nathaniel Morris. (Washington Post)

Mylan has agreed to pay $465 million "to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen," Deena Beasley reports. (Reuters)

Bertrand Bell, MD, who campaigned for resident work hour reform following the death of Libby Zion in 1984, has died. He was 86. (Sam Roberts, The New York Times)

The Surgeon General's office is investigating a possible breach of a computer system that maintains personal information from more than 6,700 doctors, nurses and other health care workers. (AP, via ABC News)

Healthcare professionals are streaming into Haiti to help those affected by Hurricane Matthew. (Makini Brice and Joseph Guyler Delva, Reuters)

Care at hospitals for Native Americans is often substandard, according to the Department of Health and Human Services' Office of the Inspector General. (Regina Garcia Cano, AP)

Anthem won't cover Exondys 51, Sarepta's newly approved drug for Duchenne muscular dystrophy. (Natalie Grover, Reuters)

"By Spinning Early Results, CMS May Be Undermining Payment Reform," says John O'Shea. (Health Affairs blog)

Is radiology doomed? asks David E. Williams. (Health Business Blog)

Bob Doherty has an answer for direct primary care evangelists. (ACP Advocacy Blog)

"I'm a Doctor," says Aaron Carroll, MD. "If I Drop Food on the Kitchen Floor, I Still Eat It." (The New York Times)

Should researchers study homeopathy? asks Helen Branswell. (STAT)

Last week, amid rising concerns about drug price hikes, Ariad raised the price of leukemia drug Iclusig for the fourth time this year, Adam Feuerstein reports, making its cost nearly $199,000 per year. (The Street)

Don't want the FDA to inspect your plant? Just have your workers create a human barricade, the way this company did. (Ed Silverman, STAT)

A year after the much-hyped ICD-10 changeover, the drama is over, but the benefits are yet to be seen, writes Joseph Conn. (Modern Healthcare)

When it comes to chemotherapy, the 340B Drug Discount Program is actually driving up costs, says Debra Patt, MD. (STAT)

Rapunzel syndrome: A case report. (Julia Belluz, Vox)

Nanotechnology for a better menstrual pad? One researcher hopes so. (Erin Blakemore, Washington Post)

"Rising Premiums Rankle People Paying Full Price For Health Insurance," reports Virginia Anderson. (Kaiser Health News via NPR)

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.